Document Classification

Section Type: RESULTS

Text: Patients treated with esmolol (atrial natriuretic peptide : 2. 46 + / - 0. 75 microg mL (-1) brain natriuretic peptide : 4. 34 + / - 3. 06 microg mL (-1)) and sodium nitropusside (atrial natriuretic peptide : 2. 48 + / - 0. 92 microg mL (-1) ; brain natriuretic peptide : 4. 49 + / - 3. 21 microg mL (-1)) showed significantly lower concentrations of atrial and brain natriuretic peptide at T2 and T3 compared with controls (atrial natriuretic peptide : 5. 31 + / - 2. 32 microg mL (-1) ; brain natriuretic peptide : 13. 26 + / - 8. 98 microg mL (-1)), P < 0. 01) as well as a reduction in blood loss and duration of surgery.